Knowledge of menopause and hormone replacement therapy use in low-income urban women

Journal of Women's Health and Gender-Based Medicine

Volumn 9, Issue 1, 2000, Pages 57-64

  Appling, Susan E ^a   Allen, Jerilyn K ^a   Van Zandt, Shirley ^a   Olsen, Sharon ^a   Brager, Rosemarie ^a   Hallerdin, Jule ^b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b UNIVERSITY OF THE VIRGIN ISLANDS   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; EDUCATION; FEMALE; GROUPS BY AGE; HEALTH EDUCATION; HEART DISEASE; HORMONE SUBSTITUTION; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MENOPAUSE; POPULATION RESEARCH; PREDICTION; PRIORITY JOURNAL; SOCIOECONOMICS; URBAN AREA;

CROSS-SECTIONAL STUDIES; FEMALE; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HORMONE REPLACEMENT THERAPY; HUMANS; MENOPAUSE; MIDDLE AGED; POSTMENOPAUSE; POVERTY; REGRESSION ANALYSIS; SOCIOECONOMIC FACTORS; URBAN POPULATION;

EID: 0034102485     PISSN: 15246094     EISSN: None     Source Type: Journal    
DOI: 10.1089/152460900318975     Document Type: Article

References (47)

1. U.S. Department of Commerce, Bureau of Census. Statistical Abstract of the United States, 1989.
2. Grady D, Rubin SM, Petitti DB, et al. Hormone therapy to prevent disease and prolong life in post-menopausal women. Ann Intern Med 1992;20:1016.
3. Stampfer MJ, Colditz GA. Estrogen replacement and coronary heart disease. A quantitative assessment of the epidemiologic evidence. Prev Med 1991;20:47.
4. Grodstein F, Stampfer JJ, Colditz CA, et al. Post-menopausal hormone therapy and mortality. N Engl J Med 1997;336:1769.
5. Belezikian JP. Major issues regarding estrogen replacement therapy in postmenopausal women. J Women's Health 1994;3:273.
6. Kawas C, Resnick S, Morrison A, et al. A prospective study of estrogen replacement therapy and the risk of developing Alzheimer's disease: The Baltimore Longitudinal Study of Aging. Neurology 1997;48:1517.
7. Tang M, Jacobs D, Stern Y, et al. Effect of oestrogen during menopause on risk and age at onset of Alzheimer's disease. Lancet 1996;348:439.
8. Brett KM, Madans, HJ. Use of postmenopausal hormone replacement therapy: Estimates from a nationally representative cohort study. Am J Epidemiol 1997;145:536.
9. Pilote L, Hlatky MA. Attitudes of women toward hormone therapy and prevention of heart disease. Am Heart J 1995;129:1237.
10. Cauley JA, Cummings SR, Black DM, Mascioli SR, Seeley DG. Prevalence and determinants of estrogen replacement therapy in elderly women. Am J Obstet Gynecol 1990;163:1438.
11. Harris RB, Laws A, Reddy VM, King A, Haskell WL. Are women using postmenopausal estrogens? A community survey. Am J Public Health 1990;80:1266.
12. Stafford RS, Saglam D, Causion N, Blumenthal D. Low rates of hormone replacement in visits to United States primary care physicians. Am J Obstet Gynecol 1997;177:381.
13. Derby CA, Hume AL, Barbour MM, McPhillips JB, Lasater TM, Carleton RA. Correlates of postmenopausal estrogen use and trends through the 1980's in two southeastern New England communities. Am J Epidemiol 1993;137:1125.
14. Bartman BA, Moy E. Racial differences in estrogen use among middle-aged and older women. Women's Health Issues 1998;8:32.
15. Egeland GM, Matthews KA, Kuller LH, Kelsey SF. Characteristics of noncontraceptive hormone users. Pre Med 1988;17:403.
16. Handa VL, Landerman R, Hanlon JT, Harris T, Cohen HJ. Do older women use estrogen replacement? Data from the Duke Established Populations for Epidemiologic Studies of the Elderly (EPESE). J Am Geriatr Soc 1996;44:1.
17. National Center for Health Statistics. Annual summary of births, marriages, divorces and deaths: United States, 1992. Monthly Vital Statistics Report 41, 1993;13. Hyattsville, MD: Public Health Service.
18. Gillum MF, Mussolino ME, Madans GH. Coronary heart disease incidence and survival in African-American women and men. Ann Intern Med 1997;127:111.
19. Ghali WA, Freund KM, Boss, RD, Ryan CA, Moskowitz MA. Menopausal hormone therapy: Physician awareness of patient attitudes. Am J Med 1997;103:3.
20. Leveille SG, LaCroix AZ, Newton KM, Keenan NL. Older women and hormone replacement therapy: Factors influencing late life initiation. J Am Geriatr Soc 1997;45:1496.
21. McNagny SE, Wenger NK, Frank E. Personal use of postmenopausal hormone replacement therapy by women physicans in the United States. Ann Intern Med 1997;127:1093.
22. Jahnige K, Fiebach N. Postmenopausal estrogen use among African-American and white patients at an urban clinic. J Women's Health 1997;6:93.
23. Salamone LM, Pressman AR, Seeley DG, Cauley JA. Estrogen replacement therapy: A survey of older women's attitudes. Arch Intern Med 1996;156:1293.
24. Newton KM, Lacroix AZ, Leveille SG, Rutter C, Keenan NL, Anderson LA. The physician's role in women's decision making about hormone replacement therapy. Obstet Gynecol 1998;93:580.
25. McNagny SE, Jacobson TA. Use of postmenopausal hormone replacement therapy by African-American women: The importance of physician discussion. Arch Intern Med 1997;157:1337.
26. Ferguson JJ, Curtis H, Johnson S. Estrogen replacement therapy: A survey of women's knowledge and attitudes. Arch Intern Med 1989;149:133.
27. Groeneveld FPMJ, Bareman FP, Baentsen R, Dokter HJ, Drogendijk AC, Hoes AW. Duration of hormonal replacement therapy in general practice: A follow-up study. Maturitas 1998;9:125.
28. Ravnikar VA. Compliance with hormone therapy. Am J Obstet Gynecol 1987;156:1332.
29. Ryan PJ, Harrison R, Blake GM, Fogelman I. Compliance with hormone replacement therapy (HRT) after screening for postmenopausal osteoporosis. Br J Obstet Gynaecol 1992;99:325.
30. Wallace WA, Price VH, Elliot CA, MacPherson MBA, Scott BW. Hormone replacement therapy acceptability to Nottingham post-menopausal women with a risk factor for osteoporosis. J R Soc Med 1990;83:699.
31. Hammond CB, Maxson WS. Current status of estrogen therapy for the menopause. Fertil Steril 1982;37:5.
32. Hahn RG, Nachtigall RD, Davies TC. Compliance difficulties with progestin-supplemented estrogen replacement therapy. J Fam Pract 1984;18:411.
33. Place VA, Powers M, Darley PE, Schenkel L, Good WR. A double-blind comparative study of Estraderm and Premarin in the amelioration of postmenopausal symptoms. Am J Obstet Gynecol 1985;152:1092.
34. Holmes-Rovner M, Padonu G, Kroll J, et al. African-American women's attitudes and expectations of menopause. Am J Prev Med 1996;12:420.
35. Standing TS, Glazer G. Attitudes of low-income clinic patients toward menopause. Health Care Women Int 1992;13:271.
36. Allen J, Appling S, Bellantoni M, et al. Factors associated with hormone replacement therapy use in low income urban women. Women's Health Issues 1999;9: 319.
37. Breast and Cervical Cancer Mortality and Prevention Act of 1990, Pub. L. No. 101-354, August 10, 1990, vol. 104. U.S. Statutes at Large, p. 409.
38. Blair KA, White N. Are older women offered adequate healthcare? J Gerontol Nurs 1998;24(10):39.
39. Ranson S, Guerin M, Holmes-Rovner M, Dodson MC, Padonu G. The impact of ethnicity on attitudes and beliefs about estrogen replacement therapy among Michigan nurses. J Natl Black Nurs Assoc 1996;82:38.
40. American College of Physicians. Guidelines for counseling postmenopausal women about preventive hormone therapy. Ann Intern Med 1992;117:1038.
41. American College of Obstetricians and Gynecologists. Hormone replacement therapy. Washington, DC: American College of Obstetricians and Gynecologists, 1992;166:1.
42. Canadian Task Force on the Periodic Health Examination. Canadian guide to clinical preventive health care. Ottawa, Ontario: Canada Communication Group, 1994.
43. U.S. Preventive Services Task Force. Guide to clinical preventive services. 2nd ed. Baltimore, MD: Williams & Wilkins, 1996.
44. American Academy of Family Physicians. 1997-1998 AAFP reference manual - Clinical policies. Kansas City, MO: AAFP.
45. American Association of Clinical Endocrinologists. AACE clinical practice guidelines for the prevention and treatment of postmenopausal osteoporosis. Endocr Pract 1996;2:155.
46. Taira DA, Safran DG, Seto TB, Rogers WH, Tarlov AR. The relationship between patient income and physician discussion of health risk behaviors. JAMA 1997; 278:1412.
47. Lydakis C, Kerr H, Hutchings K, et al. Women's awareness of, and attitudes towards, hormone replacement therapy: Ethnic differences and effects of age and education. Int J Clin Pract 1998;52:7.